Gabay Avraham
Chief Financial Officer
Gabay Avraham has filed 6 SEC Form 4 filings (7 transaction rows) across 2 companies, including ORMP, LFWD, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.
On the most recent filing, Gabay Avraham is listed as Chief Financial Officer at ORAMED PHARMACEUTICALS INC. Inside the rolling window, Gabay Avraham reported no open-market purchases and 1 open-market sale totaling $331K in ORMP.
Companies traded
Other insiders at ORMP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$331K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gabay Avraham made?
Gabay Avraham has filed 6 SEC Form 4 filings (7 transaction rows) across 2 companies, including ORMP, LFWD since 2026.
Which companies does Gabay Avraham trade?
Gabay Avraham has filed SEC Form 4 disclosures for 2 companies, including ORMP, LFWD.
When was Gabay Avraham's most recent SEC Form 4 filing?
Gabay Avraham's most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.
What is Gabay Avraham's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gabay Avraham is listed as Chief Financial Officer.
What is Gabay Avraham's total buy and sell value in the current window?
Inside the rolling retention window, Gabay Avraham bought $0 and sold $331K based on SEC Form 4 filings.
What was Gabay Avraham's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 73,360 ORMP shares on 2026-07-01, worth $331K, per SEC Form 4 filings.